Clinical Trial Update: Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX] [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating NETrin Abs in combination with azacitidine and venetoclax for refractory acute myeloid leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• NETrin Abs
• Venetoclax (venetoclax)

Snippet

Sponsor: Centre Leon Berard | Conditions: Acute Myeloid Leukemia Refractory | Phase 1, Phase 2 | Status: TERMINATED